|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cellvation, Inc.
| | | Phone: | (212) 554-4520 | Year Established: | 2016 | Ticker: | FBIO | Exchange: | NASDAQ | Main Contact: | Frank Taffy, Co-Founder, Interim CEO & President | | Other Contacts: | Lucy Lu, MD, Executive VP & CFO
| |
| Company Description | Cellvation, a Fortress Biotech subsidiary, is developing novel therapies for the treatment of traumatic brain injury. Cellvation has entered into an agreement with The University of Texas Health Science Center at Houston (UTHealth) to secure exclusive worldwide rights to three programs for TBI, including two Phase 2 cell therapies. | |
|
|
|
|
|